Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02194816 · ClinicalTrials.gov registry record

Modifiable Variables in Parkinsonism (MVP)

A clinical trial of Parkinson's Disease and Dementia With Lewy Bodies, sponsored by Bastyr University.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT02194816 is a study of Parkinson's Disease and Dementia With Lewy Bodies that is actively recruiting participants, run by Bastyr University. The registered enrollment target is 2,000 participants, above the 630-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (217% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02194816, a study of Parkinson's Disease and Dementia With Lewy Bodies, is actively recruiting participants, sponsored by Bastyr University.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate, we will ask participants to fill our questionnaires about their experience with PD, their health in general, along with their food intake every six months for five years.

Study Locations (1)

Washington

  • Bastyr University - Kenmore

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2012-09
Est. Completion 2030-12

Sponsor

Bastyr University

19 total trials

What the Registry Record Tells You About NCT02194816

The ClinicalTrials.gov registry entry for NCT02194816 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 630-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (217% higher). The listed sponsor is Bastyr University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02194816 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02194816 about?

NCT02194816 is a clinical study titled "Modifiable Variables in Parkinsonism (MVP)". We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate...

What is the current status of trial NCT02194816?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2012-09. Estimated completion is 2030-12.

What conditions does trial NCT02194816 study?

This clinical trial studies the following conditions: Parkinson's Disease, Dementia With Lewy Bodies, Progressive Supranuclear Palsy, Corticobasal Degeneration, Parkinsonism.

Who is sponsoring clinical trial NCT02194816?

This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02194816 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.